Abstract
BACKGROUND AND AIMS: The relative contributions of alcohol-associated and cardiometabolic drivers to liver-related events (LREs) remain unknown. We aimed to evaluate their relative contributions to LREs and examine possible interactions.
APPROACH AND RESULTS: A total of 329,526 UK Biobank participants were included. Alcohol consumption was self-reported and categorized by weekly consumption as low (<140 g for females, <210 g for males), intermediate (140-350 g for females, 210-420 g for males), and high (>350 g for females, >420 g for males). Five cardiometabolic risk factors (CMRFs) were identified using diagnostic criteria for metabolic dysfunction-associated steatotic liver disease. Over a median follow-up of 12.8 years, 1809 LREs were documented. Alcohol consumption showed the strongest association with LREs. Among participants with low alcohol intake, pre-diabetes/diabetes (HR: 1.87, 95% CI: 1.64-2.14), low HDL cholesterol (1.79, 1.53-2.10), overweight/obesity (1.68, 1.40-2.01), hypertension (1.27, 1.06-1.53), and overall CMRF burden (5.61, 3.66-8.62) were associated with increased risk of LREs. The corresponding values for intermediate alcohol consumption were 2.00 (1.64-2.43), 1.47 (1.16-1.86), 1.19 (0.92-1.54), 1.90 (1.36-2.64), 5.95 (2.84-12.45); and for high consumption, 1.48 (1.17-1.87), 1.47 (1.11-1.95), 0.88 (0.66-1.18), 1.30 (0.88-1.94), 1.17 (0.58-2.34), respectively. A multiplicative interaction was observed between high alcohol consumption and CMRFs, but not between intermediate consumption and CMRFs.
CONCLUSIONS: Excessive alcohol use appears to be the strongest factor associated with LREs. Associations between CMRFs and LREs seem similar among individuals with low and intermediate alcohol intake. Reducing alcohol intake, alongside targeted management of CMRFs, may improve strategies for preventing severe liver disease.